Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (3r)-3-(((trans-4-((2-aminoethyl)amino)cyclohexyl)acetyl)amino)-2-hydroxy-3,4-dihydro-2h-1,2-benzoxaborinine-8-carboxylic Acid
2. 2h-1,2-benzoxaborin-8-carboxylic Acid, 3-((2-(trans-4-((2-aminoethyl)amino)cyclohexyl)acetyl)amino)-3,4-dihydro-2-hydroxy-, (3r)-
3. Vnrx-5133
1. 1613267-49-4
2. Vnrx-5133
3. Vnrx5133
4. Taniborbactam [inn]
5. Taniborbactam [usan]
6. Taniborbactam Free Base
7. 8igq156z07
8. (3r)-3-[[2-[4-(2-aminoethylamino)cyclohexyl]acetyl]amino]-2-hydroxy-3,4-dihydro-1,2-benzoxaborinine-8-carboxylic Acid
9. 2h-1,2-benzoxaborin-8-carboxylic Acid, 3-((2-(trans-4-((2-aminoethyl)amino)cyclohexyl)acetyl)amino)-3,4-dihydro-2-hydroxy-, (3r)-
10. (3~{r})-3-[2-[4-(2-azanylethylamino)cyclohexyl]ethanoylamino]-2-oxidanyl-3,4-dihydro-1,2-benzoxaborinine-8-carboxylic Acid
11. Taniborbactam (usan/inn)
12. Unii-8igq156z07
13. Chembl4463697
14. Chembl4584705
15. Chembl4594290
16. Schembl15778142
17. Schembl15778144
18. Schembl15779391
19. Gtpl10774
20. Ex-a5157
21. Who 10817
22. Hy-109124
23. Cs-0078360
24. D11718
25. (3r)-3-(((trans-4-((2-aminoethyl)amino)cyclohexyl)acetyl)amino)-2-hydroxy-3,4-dihydro-2h-1,2-benzoxaborinine-8-carboxylic Acid
26. (3r)-3-((2-(trans-4-((2-aminoethyl)amino)cyclohexyl)acetyl)amino)-3,4-dihydro-2-hydroxy-2h-1,2-benzoxaborin-8-carboxylic Acid
27. (r)-3-(2-((1s,4r)-rel-4-((2-aminoethyl)amino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2h-benzo[e][1,2]oxaborinine-8-carboxylic Acid
28. (r)-3-(2-((1s,4r)-rel-4-((2-aminoethyl)amino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2h-benzo[e][1,2]oxaborinine-8-carboxylicacid
29. (r)-3-(2-(trans-4-(2-aminoethylamino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2h-benzo[e][1,2]oxaborinine-8-carboxylic Acid
| Molecular Weight | 389.3 g/mol |
|---|---|
| Molecular Formula | C19H28BN3O5 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 7 |
| Exact Mass | 389.2122012 g/mol |
| Monoisotopic Mass | 389.2122012 g/mol |
| Topological Polar Surface Area | 134 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 544 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Taniborbactam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Taniborbactam, including repackagers and relabelers. The FDA regulates Taniborbactam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Taniborbactam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Taniborbactam supplier is an individual or a company that provides Taniborbactam active pharmaceutical ingredient (API) or Taniborbactam finished formulations upon request. The Taniborbactam suppliers may include Taniborbactam API manufacturers, exporters, distributors and traders.
Taniborbactam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Taniborbactam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Taniborbactam GMP manufacturer or Taniborbactam GMP API supplier for your needs.
A Taniborbactam CoA (Certificate of Analysis) is a formal document that attests to Taniborbactam's compliance with Taniborbactam specifications and serves as a tool for batch-level quality control.
Taniborbactam CoA mostly includes findings from lab analyses of a specific batch. For each Taniborbactam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Taniborbactam may be tested according to a variety of international standards, such as European Pharmacopoeia (Taniborbactam EP), Taniborbactam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Taniborbactam USP).
LOOKING FOR A SUPPLIER?
